Properidine

Properidine is a synthetic opioid and is part of the piperidine class of analgesic agents. It is primarily used in the management of moderate to severe pain. Properidine is also known by its trade name, Rhotral, and is classified as a Schedule I drug under the Controlled Substances Act in the United States.
Pharmacology[edit]
Properidine acts as a mu-opioid receptor agonist. This receptor is a G protein-coupled receptor that mediates the effects of opioids. When properidine binds to the mu-opioid receptor, it inhibits the release of GABA, a neurotransmitter that inhibits the release of dopamine. This results in an increase in dopamine release, which contributes to the analgesic effects of the drug.
Clinical Use[edit]
Properidine is used for the management of moderate to severe pain. It is often used in situations where other analgesics, such as nonsteroidal anti-inflammatory drugs (NSAIDs) or paracetamol, are not effective. Properidine can be administered orally, intramuscularly, or intravenously.
Side Effects[edit]
Like other opioids, properidine has a number of side effects. These can include nausea, vomiting, constipation, and respiratory depression. In addition, properidine can cause physical dependence and withdrawal symptoms if used for a prolonged period of time.
Legal Status[edit]
In the United States, properidine is classified as a Schedule I drug under the Controlled Substances Act. This means that it has a high potential for abuse and no accepted medical use. In other countries, the legal status of properidine may vary.
See Also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
